
A new state-of-the-art review on risk prediction in cardio-oncology, and an invitation to help build the tools this field still needs.

The moderate aortic stenosis risk score is a new clinical tool designed to predict who is truly at risk of cardiac death or heart failure hospitalisation — and who is likely to do well. If you have…

Dr Jonathan Sen explains why a full year of dedicated cardio-oncology fellowship, with integrated imaging and research at UHN Toronto, shapes better cardiac care for cancer patients in Brisbane.

For clinicians on the front line, including GPs, emergency physicians, and oncologists, the question is what to do when a troponin comes back elevated in someone receiving immunotherapy. Not every troponin rise means myocarditis. But missing the…

Thanks to current advances in chemotherapy, immunotherapy, targeted therapies, and radiation techniques, five-year survival rates for a range of malignancies have improved dramatically—from 50% in the late 1980s to 72% in 2017–2021 (Australian Institute of Health and…

I remember the moment that changed how I think about medicine. A woman in her sixties had survived breast cancer, endured years of treatment, navigated the fear of recurrence, and finally achieved hard-won remission, only to develop…